Search
Research outputs
Pooled efficacy and cardiovascular safety results of roxadustat compared with placebo/ darbepoetin alfa for treatment of anaemia in patients with non-dialysis-dependent (NDD) chronic kidney disease (CKD) [2021]
Barratt, Jonathan; Dimkovic, Nada B; Shutov, Evgeny; Sulowicz, Wladyslaw; Esposito, Ciro; Reusch, Michael; Young, James; Mariat, ChristopheRoxadustat for the treatment of anemia in chronic kidney disease (CKD) patients not on dialysis (NDD): a phase 3, randomized, open-label, active-controlled study [2020]
Barratt, Jonathan; Andric, Branislav R; Tataradze, Avtandil; Schoemig, Michael; Reusch, Michael; Valluri, UdayaPrevalence of SARS-CoV-2 positivity in infants with bronchiolitis: a multicentre international study [2022]
Cozzi, Giorgio; ...; Gojsina, Bojana Z; ...; Sovtic, Aleksandar D![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
LMWHs have an additional advantage over unfractionated heparin: no volume load (✓) [2009]
Koracevic, Goran P![](/image/people_icon_ico.png)
![](/image/organisations_icon_ico.png)
Racial differences in SSc disease presentation: a European scleroderma trials and research group (EUSTAR) study [2018]
Jaeger, Veronika K; ...; Damjanov, Nemanja S; ...; (broj, koautora 26)Cardiovascular Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or Not Receiving Dialysis: Pooled Subgroup Analysis of Four Phase 3 Studies [2022]
Esposito, Ciro; Barratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Reusch, Michael; Young, James; Jiletcovici, Alina; Dimkovic, Nada BRandomized, double-blind, phase II study of tiragolumab plus atezolizumab versus placebo plus atezolizumab as first-line treatment for PD-L1-selected NSCLC (CITYSCAPE) [2020]
Rodriguez-Abreu, Delvys; ...; Secen, Nevena M; ...; (broj, koautora 21)Obesity - risk factor for doctors' health [2009]
Vukadinovic, Nada; Cimbaljevic, BrankoCardiovascular outcomes associated with achieved haemoglobin level and preliminary rate of rise of haemoglobin in pooled phase 3 studies of roxadustat in non-dialysis-dependent patients with anaemia [2021]
Barratt, Jonathan; Sulowicz, Wladyslaw; Cockburn, Elinor; Reusch, Michael; Young, James; Dimkovic, Nada BClinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 [2020]
Herbst, Roy S; ...; Andric, Zoran G; ...; (broj, koautora 21)Filters
By type
- 15